| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.24 | 2e-06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.11 | 0.06 |